Topical roflumilast formulation having improved delivery and plasma half-life | Patent Application Number 18353869

18353869
Not Appealed
Patent NumberUS 12005052 B2
Publication NumberUS 20230364066 A1
Filled DateJul 17, 2023
Priority DateJun 7, 2017
Inventor/ApplicantsDavid W. OSBORNE
David W. Osborne
ExaminesHOWELL, THEODORE R.
Art Unit1628
Technology Center1600
Assignments
Iplg Llp
Current
Arcutis Biotherapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.